Literature DB >> 444848

Extra-intracranial revascularization.

J S Lumley.   

Abstract

Twenty-four extra-intracranial revascularization procedures were undertaken in 23 patients with occlusion of the ipsilateral internal carotid artery. The superficial temporal artery was anastomosed to a cortical branch of the middle cerebral artery in 23 cases and a vein graft inserted between the external carotid artery and the cortical vessel in 1, a microsurgical technique being used. Twenty-one patients were suffering from transient ischaemic attacks (TIAs) and 2 had developing strokes. Nineteen patients had radiologically demonstrated bilateral disease of the carotid vessels, 9 having undergone contralateral carotid artery surgery before the intracranial procedure. No improvement was noted in the 2 patients with developing strokes; one patient developed a stroke contralateral to the intracranial procedure 24 h postoperatively, this being accompanied by occlusion of the anastomoses, and one patient had progression of the stroke syndrome following occlusion of the intracranial vein graft. All other patients have shown a reduction of abolition of TIAs over a follow-up period of 24 months. These findings suggest that intracranial revascularization is of value in patients with total internal carotid artery occlusion and continuing TIAs.

Entities:  

Mesh:

Year:  1979        PMID: 444848     DOI: 10.1002/bjs.1800660507

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Confusion after admission to hospital in elderly patients using benzodiazepines.

Authors:  C E Daman Willems; M J Dillon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

2.  Cerebral revascularisation in stroke prophylaxis.

Authors:  J S Lumley
Journal:  Ann R Coll Surg Engl       Date:  1980-09       Impact factor: 1.891

3.  Brain revascularisation in hypertension.

Authors:  C E Willems; D M Salisbury; J S Lumley; M J Dillon
Journal:  Arch Dis Child       Date:  1985-12       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.